Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Trial of HSV G207 Alone or With a Single Radiation Dose in Children With Recurrent Supratentorial Brain Tumors

NCT02457845 is registered in ClinicalTrials.gov with Gregory K. Friedman, MD as lead sponsor.

NCT NCT02457845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02457845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Trial of HSV G207 Alone or With a Single Radiation Dose in Children With Recurrent Supratentorial Brain Tumors
Lead sponsor
Gregory K. Friedman, MD
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2016
Completion date
January 31, 2024
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, cerebral primitive neuroectodermal tumor, embryonal tumor, glioblastoma, malignant glioma, pnet, supratentorial neoplasms, malignant